We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Arrowhead Prices $36 Million Private Offering

News   May 01, 2013

 
Arrowhead Prices $36 Million Private Offering
 
 
 

RELATED ARTICLES

Bacteria Bide Their Time When Antibiotics Attack

News

If an antibiotic doesn’t kill all the bacteria that infects a patient, the surviving bugs may be particularly adept at timing their resurgence.

READ MORE

Antibodies Stabilize Plaque in Arteries

News

An unexpected role for type IgG antibodies has been identified, after a study in mice showed that the antibodies stabilize the plaque that accumulates on the artery walls, reducing the risk of rupture and blood clot.

READ MORE

Microbe Motility Enhanced by Microbiome Metabolites in Colon Chip

News

By leveraging an organ-on-a-chip model and a bioreactor, four human gut metabolites have been identified that can help explain the enhanced sensitivity of the human colon towards enterohemorrhagic E. coli, which is responsible for more than 100,000 infections per year in the USA alone.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE